ARTICLE | Financial News

7 adds to NASDAQ Biotech Index

November 12, 2001 8:00 AM UTC

The NASDAQ Biotechnology Index added 7 new components: discovery services play Albany Molecular (AMRI); immunotherapeutics developer Corixa (CRXA); Exelixis (EXEL), which is using comparative genomics and model system genetics for drug discovery; cancer antisense play Genta (GNTA); Immunomedics (IMMU), a developer of therapeutics and diagnostics for cancer and infectious diseases; antisense company Isis (ISIP); and research services play Invitrogen (IVGN). ...